Why Nevro Is Falling So Hard Today
Specialty medical device maker Nevro (NYSE: NVRO) had an awful Thursday, with its shares collapsing by over 24% in late afternoon trading. Investors were punishing the company for a worse-than-expected second-quarter earnings report.
In terms of headline numbers, Nevro's performance for the quarter was mixed. It earned $102.3 million in revenue, nearly double the $56.4 million it booked in the same period a year ago. However, the former didn't reach the collective analyst estimate of $104.5 million.
Image source: Getty Images.
Source Fool.com
